Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Kairos Pharma (KAPA) Q4 2024 Earnings
KAPA
14
Nov
Confirmed
Q1 1
Q4 2024
-0.05
-0.04
-0.03
-0.02
Details
Expected EPS
-0.02
Actual EPS
-0.05
Surprise EPS
-0.03
Surprise Percent
+150%
Description
Kairos Pharma (KAPA) has reported earnings of -0.05 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login